Does type 2 diabetes increase your risk of dementia?

Type 2 diabetes increases the risk of both Alzheimer's disease and vascular dementia. This association has been consistently demonstrated across multiple studies. Notably, the brains of people with diabetes do not always show the classic Alzheimer's features (plaques and protein tangles) to the same degree. This suggests that diabetes contributes to brain decline through its own pathways, not exclusively through the well-known Alzheimer's route.

The younger you are when you develop diabetes, the greater the risk. People who were diagnosed with diabetes more than ten years before the age of 70 had more than twice the chance of developing dementia compared with someone of that age without diabetes. For every five years earlier the disease begins, roughly 24% additional risk is added on top. This makes timely prevention and treatment especially relevant for people who receive a diagnosis in early or middle age.

Nearly half of all people with type 2 diabetes show signs of mild cognitive impairment, a precursor to dementia. This figure comes from a meta-analysis of twelve observational studies, but those studies differed considerably from one another, so this percentage is an estimate with wide margins.

A possible connecting link is insulin resistance in the brain itself. Whether diabetes and dementia reinforce each other through a vicious cycle, or whether both arise from the same underlying risk factors, has not yet been clarified. There is also research showing that inflammatory processes and disrupted fatty acid metabolism play a role, but these remain observational findings for now, not a proven cause-and-effect relationship.

For people who already have type 2 diabetes, certain medication choices appear to make a difference. GLP-1 receptor agonists (such as semaglutide) were linked in observational research to a 33% lower risk of dementia compared with other blood-sugar-lowering drugs. SGLT2 inhibitors (such as empagliflozine) showed an even lower risk of 43%. These are not randomised trials, so the results may partly reflect the fact that healthier patients are more often prescribed these medications. Nevertheless, the signal is strikingly consistent. One older class of pills, the sulphonylureas, was the only diabetes medication actually associated with an increased risk of dementia. If you have diabetes and have doubts about your medication, this is certainly worth discussing with your doctor.